×

BRIEF-Cell Therapeutics announces public offering of convertible preferred stock

Oct 4 (Reuters) - Cell Therapeutics Inc :

* Announces proposed public offering of convertible preferred stock

* It intends to offer 40,000 shares of its series 17 preferred stock

* To offer and sell, subject to market and other conditions, 40,000 shares of

its series 17 preferred stock

* Says each share of series 17 preferred stock will have a stated value of

$1,000 per share

* Cti plans to use the net proceeds from this offering to support the launch of

pixuvri in Europe

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))